Analyst Ratings for Rapt Therapeutics (RAPT)
RAPT Rating Summary
RAPT Price Target Summary
- Highest: $58.00 (Wells Fargo)
- Lowest: $9.00 (UBS)
- Average: $51.75
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$51.75 (-10.8%)
* Over Last 12-Mos
Rating Score: 3.5 / 10
Percentile Rank: 33%
Avg. $ Target:
$51.75 (-10.8%)
* Over Last 12-Mos
Rating Score: 3.5 / 10
Percentile Rank: 33%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/21/2026 | Barclays | Etzer Darout | Downgrade | Equalweight (Overweight) |
58.00 (N/A) |
57.57 (58.02) |
0.78% | Details |
| 1/21/2026 | Leerink Partners | Thomas Smith | Downgrade | Market Perform (Outperform) |
58.00 (60.00) |
35.10 (58.02) |
65.3% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
